Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.

Kazim, Sabiha

Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer. [electronic resource] - Molecular cancer therapeutics Jul 2015 - 1570-81 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1538-8514

10.1158/1535-7163.MCT-15-0104 doi


Active Transport, Cell Nucleus--drug effects
Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Blotting, Western
Cell Adhesion--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Cyclin-Dependent Kinase Inhibitor p27--metabolism
Deoxycytidine--administration & dosage
Dose-Response Relationship, Drug
Drug Synergism
Female
Humans
Hydrazines--administration & dosage
Mice, Nude
Microscopy, Confocal
Pancreatic Neoplasms--drug therapy
Triazoles--administration & dosage
Tumor Burden--drug effects
Xenograft Model Antitumor Assays
Gemcitabine